EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Penicillin V versus amoxicillin for pneumonia in children—a Swedish nationwide emulated target trial

Samuel Rhedin, Beatrice Kvist, Emma Caffrey Osvald, Gale Karte, Awad I Smew, Pontus Nauclér, Cecilia Lundholm, Catarina Almqvist

Clinical Microbiology and Infection · 2024

DOI: 10.1016/j.cmi.2024.06.008 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Microbiology and Infection, 2024. Verfasst von Samuel Rhedin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Sachs' Children and Youth Hospital, Stockholm, Sweden…. Hauptthemen laut MEDLINE: Amoxicillin, Anti-Bacterial Agents, Penicillin V. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asthma and Allergy Association, Swedish Heart and Lung Association, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Although most countries recommend amoxicillin for paediatric pneumonia, there is a long tradition of treatment with penicillin V (PcV) in Sweden, thus not empirically covering Haemophilus influenzae. There are, however, large regional differences in treatment practice. The aim was to compare clinical outcomes (treatment failure and severe complications), in children aged 1-59 months treated with PcV vs. amoxicillin for pneumonia. METHODS: This population-based emulated target trial included all children born in Sweden between 2001 and 2021, using national health, sociodemographic, and population registers. All pneumonia cases from hospitals and paediatric outpatient clinics in children aged 1-59 months treated as outpatients with PcV or amoxicillin between July 2005 and December 2021, were identified. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for treatment failure (newly dispensed antibiotic prescription or pneumonia-associated hospitalization day 1-14) and severe complications (lung complications, an invasive bacterial disease, admission to intensive care unit or death day 1-28) were calculated with logistic regression analysis. RESULTS: PcV was prescribed in 14 766 cases and amoxicillin in 10 566. Treatment failure occurred in 7.7% with PcV vs. 4.7% with amoxicillin, aOR 1.76 (95% CI: 1.54-2.00). Severe complications were rare, with no significant difference between PcV and amoxicillin (0.3% vs. 0.2%, aOR 0.96, 95% CI: 0.53-1.73). Sensitivity and interaction analyses showed consistent results. DISCUSSION: PcV treatment compared with amoxicillin, was associated with an increased risk for treatment failure but not for severe complications. The absolute risks for adverse outcomes were low in both groups suggesting a minor role of H. influenzae in paediatric pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmoxicillinAnti-Bacterial AgentsPenicillin VHumansSwedenInfantChild, PreschoolFemaleMalePneumoniaTreatment FailureTreatment OutcomeHospitalization

Stichwörter der Autor:innen

AmoxicillinAntibioticsChildrenPaediatric infectious diseasesPenicillinPneumonia

Substanzen

AmoxicillinAnti-Bacterial AgentsPenicillin V

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Sachs' Children and Youth Hospital, Stockholm, Sweden. Electronic address: samuel.rhedin@ki.se.
  • Department of Internal Medicine, Kungälv Hospital, Sweden.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Paediatric Allergy and Pulmonology Unit at Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm,…
  • Sachs' Children and Youth Hospital, Stockholm, Sweden.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
  • Division of Infectious Diseases, Department of Medicine, Solna (MedS), Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Förderung

  • Asthma and Allergy Association
  • Swedish Heart and Lung Association
  • Swedish Research Council

Zitieren

APA

Rhedin, S., Kvist, B., Caffrey Osvald, E., Karte, G., Smew, A. I., Nauclér, P., Lundholm, C., & Almqvist, C. (2024). Penicillin V versus amoxicillin for pneumonia in children—a Swedish nationwide emulated target trial. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.06.008

Vancouver

Rhedin S, Kvist B, Caffrey Osvald E, Karte G, Smew AI, Nauclér P, et al. Penicillin V versus amoxicillin for pneumonia in children—a Swedish nationwide emulated target trial. Clinical Microbiology and Infection. 2024. doi:10.1016/j.cmi.2024.06.008

BibTeX
@article{Rhedin2024,
  author = {Rhedin, Samuel and Kvist, Beatrice and Caffrey Osvald, Emma and Karte, Gale and Smew, Awad I and Nauclér, Pontus and Lundholm, Cecilia and Almqvist, Catarina},
  title = {Penicillin V versus amoxicillin for pneumonia in children—a Swedish nationwide emulated target trial},
  journal = {Clinical Microbiology and Infection},
  year = {2024},
  doi = {10.1016/j.cmi.2024.06.008}
}
Kostenlos starten →